Clinical Trials Logo

Penile Cancer clinical trials

View clinical trials related to Penile Cancer.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04357873 Active, not recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma

Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations

PEVOsq
Start date: October 28, 2020
Phase: Phase 2
Study type: Interventional

Interventional study evaluating the efficacy of an immunotherapy (pembrolizumab) in combination with a targeted therapy (vorinostat) in patient with recurrent and/or metastatic squamous cell carcinoma (localisations : head and neck, lung, cervix, anus, vulva, and penis)

NCT ID: NCT04231981 Active, not recruiting - Penile Cancer Clinical Trials

Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS)

ORPHEUS
Start date: April 28, 2020
Phase: Phase 2
Study type: Interventional

This is a multicenter, open-label, single-arm, phase II clinical trial to evaluate the efficacy and safety of INCMGA00012 in Advanced Penile Squamous Cell Carcinoma

NCT ID: NCT03333616 Active, not recruiting - Clinical trials for Adrenocortical Carcinoma

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Start date: December 28, 2017
Phase: Phase 2
Study type: Interventional

This research study is studying a combination of drugs as a possible treatment for rare genitourinary malignancies among four cohorts, bladder or upper tract carcinoma with variant histology, adrenocortical carcinoma, other rare genitourinary carcinomas and any genitourinary carcinoma with neuroendocrine differentiation. Given preliminary results, the study is being tested in additional patients with bladder or upper tract carcinoma with variant histology at this time while the adrenocortical carcinoma, other rare genitourinary malignancies arms have closed to accrual -The names of the study drugs involved in this study are: - Nivolumab - Ipilimumab